Abstract
Aim:
To define the in vitro cytotoxic activities of 4-demethyl-picropodophyllotoxin 7′-O-β-D-glucopyranoside (4DPG), a new podophyllotoxin glucoside.
Methods:
Antiproliferation activity was measured in several tumor cell lines by using the microculture tetrazolium MTT assays. Cell cycle distribution was analyzed using flow cytometry and mitosis index assays. Furthermore, transmission electron microscopy, TUNEL, DNA agarose electrophoresis, and activated caspase-3 were used to analyze the induction of apoptotic cell death. Moreover, intracellular changes in the cytoskeleton were detected using immunocytochemistry.
Results:
4DPG effectively inhibited the proliferation of cancer cells (HeLa, CNE, SH-SY5Y, and K562 cell lines). For the K562 cell line, the antiproliferation effect of 4DPG was much more potent than that of etoposide (IC50 value: 7.79×10-9mol/Lfor4DPGvs 2.23 × 10−5 mol/L for etoposide). Further, 4DPG blocked the cell cycle in the mitotic phase. The induction of apoptosis and elevated levels of activated caspase-3 were confirmed in cells treated with 4DPG. The microtubule skeleton of HeLa cells was disrupted immediately after treatment with 4DPG.
Conclusion:
The cytotoxicity of 4DPG is due to its inhibition of the microtubule assembly of cancer cells at a low concentration, thus inducing apoptosis. These properties qualify 4DPG to be a potential antitumor drug.
Similar content being viewed by others
Article PDF
References
Mukherjee AK, Basu S, Sarkar N, Ghosh AC . Advances in cancer therapy with plant based natural products. Curr Med Chem 2001; 8: 1467–86.
Tsai TH . Analytical approaches for traditional Chinese medicines exhibiting antineoplastic activity. J Chromatogr B Biomed Sci Appl 2001; 764: 27–48.
Lee KH . Novel antitumor agents from higher plants. Med Res Rev 1999; 19: 569–96.
Imbert F . Discovery of podophyllotoxins. Biochimie 1998; 80: 207–22.
Cortese F, Bhattacharyya B, Wolf J . Podophyllotoxin as a probe for the colchicine binding site of tubulin. J Biol Chem 1977; 252: 1134–40.
Sackett DL . Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin. Pharmacol Ther 1993; 59: 163–228.
ter Haar E, Rosenkranz HS, Hamel E, Day BW . Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorg Med Chem 1996; 4: 1659–71.
Desbene S, Giorgi-Renault S . Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Curr Med Chem Anti-Canc Agents 2002; 2: 71–90.
Gordaliza M, Castro MA, del Corral JM, Feliciano AS . Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 2000; 6: 1811–39.
Gordaliza M, Garcia PA, del Corral JM, Castro MA, Gomez-Zurita MA . Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 2004; 44: 441–59.
Kelleher JK . Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs. Cancer Treat Rep 1978; 62: 1443–7.
Hainsworth JD, Greco FA . Etoposide: twenty years later. Ann Oncol 1995; 6: 325–41.
Schacter L . Etoposide phosphate: what, why, where, and how? Semin Oncol 1996; 23 ( Suppl 13): 1–7.
Evans WK, Eisenhauer E, Hughes P, Maroun JA, Ayoub J, Shepherd FA, et al. VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group. Br J Cancer 1988; 58: 464–8.
Splinter T, Kok T, Kho S, Lameris H, ten Kate F, Dalesio O, et al. A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer. Semin Oncol 1986; 13 ( Suppl 3): 97–103.
Aisner J, Lee EJ . Etoposide. Current and future status. Cancer 1991; 67 ( Suppl 1): 215–9.
Hande KR . Etoposide pharmacology. Semin Oncol 1992; 19 ( Suppl 13): 3–9.
Minocha A, Long BH . Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26. Biochem Biophys Res Commun 1984; 122: 165–70.
Tewey KM, Chen GL, Nelson EM, Liu LF . Intercalative antitu-mor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 1984; 259: 9182–7.
Long BH and Stringfellow DA . Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podo-phyllin congeners. Adv Enzyme Regul 1988; 27: 223–56.
Long BH . Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 1992; 19 ( Suppl 6): 3–19.
Long BH, Musial ST, Brattain MG . Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship. Biochemistry 1984; 23: 1188–94.
Paulson JC, McClure WO . Microtubules and axoplasmic transport. Inhibition of transport by podophyllotoxin: an interaction with microtubule protein. J Cell Biol 1975; 67: 461–7.
Loike JD, Brewer CF, Sternlicht H, Gensler WJ, Horwitz SB . Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Res 1978; 38: 2688–93.
Bedows E, Hatfield GM . An investigation of the antiviral activity of Podophyllum peltatum. J Nat Prod 1982; 45: 725–9.
Davis RE, Schlumpf BE, Klinger PD . Comparative neurotoxicity of tubulin-binding drugs: inhibition of goldfish optic nerve regeneration. Toxicol Appl Pharmacol 1985; 80: 308–15.
Roulland E, Magiatis P, Arimondo P, Bertounesque E, Monneret C . Hemi-synthesis and biological activity of new analogues of podophyllotoxin. Bioorg Med Chem 2002; 10: 3463–71.
Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M . Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res 2004; 64: 236–42.
Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O . The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 2004; 23: 7854–62.
Zhao C, Huang J, Hagatsu A, Ogihara Y . Two new podophyllotoxin glucosides from Sinopodophyllum emodi (Wall) Ying. Chem Pharm Bull 2001; 49: 773–5.
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.
Gundersen GG, Cook TA . Microtubules and signal transduction. Curr Opin Cell Biol 1999; 11: 81–94.
Miller KD, Sledge GW Jr . Taxanes in the treatment of breast cancer: a prodigy comes of age. Cancer Invest 1999; 17: 121–36.
Mollinedo F, Gajate C . Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003; 8: 413–50.
Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L . Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56: 816–25.
Tseng CJ, Wang YJ, Liang YC, Jeng JH, Lee WS, Lin JK, et al. Microtubule damaging agents induce apoptosis in HL60 cells and G2/M cell cycle arrest in HT29 cells. Toxicology 2002; 175: 123–42.
Wang LG, Liu XM, Kreis W, Budman DR . The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 1999; 44: 355–61.
Bhalla KN . Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003; 22: 9075–86.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30270449; No 30370196) and Beijing Natural Science Foundation (No 5052016).
Rights and permissions
About this article
Cite this article
Qi, Yl., Liao, F., Zhao, Cq. et al. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells. Acta Pharmacol Sin 26, 1000–1008 (2005). https://doi.org/10.1111/j.1745-7254.2005.00148.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00148.x
Keywords
This article is cited by
-
Synthesis and antitumor activity of novel pyridoxine-based structural analogs of saccharumoside-B
Medicinal Chemistry Research (2021)
-
Possible contribution of β-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells
Investigational New Drugs (2010)